Feb 22, 2021
BrainStorm Announces High-Level FDA Feedback on NurOwn® ALS Clinical Development Program
Feb 04, 2021
BrainStorm Announces Full Year 2020 Financial Results and Provides a Corporate Update
Jan 28, 2021
BrainStorm-Cell Therapeutics to Announce Fourth Quarter and Fiscal Year 2020 Financial Results and Provide a Corporate Update
Jan 20, 2021
BrainStorm Announces the Publication of Preclinical Data Highlighting the Potential of a NurOwn® Derived Exosome-Based Treatment for COVID-19 ARDS
Dec 28, 2020
BrainStorm Issues 2020 Letter to Shareholders
Dec 18, 2020
BrainStorm Announces Completion of All Dosing in NurOwn® Phase 2 MS Study
Oct 19, 2020
BrainStorm Announces Scientific Presentation of NurOwn® Exosome Preclinical ARDS Outcomes at the Virtual New York Stem Cell Foundation Conference
Oct 15, 2020
BrainStorm Announces Financial Results for the Third Quarter of 2020 and Provides a Corporate Update
Oct 12, 2020
BrainStorm to Present at the 2020 Cell & Gene Meeting on the Mesa
Oct 02, 2020
BrainStorm Cell Therapeutics to Announce Third Quarter Financial Results and Provide a Corporate Update
Sep 30, 2020
BrainStorm Announces Scientific Presentation at the Annual NEALS Meeting
Sep 29, 2020
BrainStorm Appoints William K. White as Senior Vice President, Head of Market Access & Pricing
Sep 16, 2020
Brainstorm Announces Grant of a New Japanese Patent for NurOwn®
Aug 25, 2020
BrainStorm to Present Data Linking MRI Measures to Functional Improvement in Progressive Multiple Sclerosis (MS)
Aug 10, 2020
BrainStorm to Present at the 40th Annual Canaccord Genuity Growth Conference
Aug 05, 2020
BrainStorm Announces Financial Results for the Second Quarter of 2020 and Provides a Corporate Update
Jul 27, 2020
BrainStorm Cell Therapeutics to Announce Second Quarter Financial Results and Provide a Corporate and R&D Update
Jul 08, 2020
BrainStorm Hosting KOL Webinar to Discuss NurOwn® Phase 2 Alzheimer's Disease Program
Jul 02, 2020
BrainStorm Announces Completion of All Dosing in NurOwn® Phase 3 Clinical Trial in ALS
Jul 01, 2020
BrainStorm to Showcase Alzheimer's Disease Clinical Program in KOL Webinar